Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1001/jama.1970.03170300072030 | DOI Listing |
Clin Nephrol Case Stud
September 2023
Medical Sub-specialties Institute, Department of Nephrology.
Intradialytic breakthrough seizures refractory to multiple classes of antiepileptic medications are not common and can be due to many different reasons. Pyridoxine deficiency is an under-recognized cause of such seizures and frequently missed in clinical practice. Many factors specifically related to dialysis can lead to pyridoxine deficiency and in turn can contribute to refractory seizures.
View Article and Find Full Text PDFCan J Neurol Sci
May 2024
Université Laval, Québec, Canada.
Case Rep Neurol
June 2022
Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Carbidopa-levodopa has been used for more than 50 years in the treatment of Parkinson disease (PD) and other movement disorders. Pyridoxal 5'-phosphate (PLP), an active form of vitamin B6 (pyridoxine), is involved in the decarboxylation of levodopa to dopamine; carbidopa, which is combined with levodopa to reduce peripheral levodopa conversion and minimize peripheral dopamine side effects, binds irreversibly with PLP. As a result, carbidopa-levodopa may cause vitamin B6 deficiency and associated sequelae, including seizures, especially in high doses.
View Article and Find Full Text PDFBrain
September 2022
Department of Neurology, Centro Hospitalar Universitário do Porto (CHUPorto), 4099-001 Porto, Portugal.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!